Wells Fargo Starts Cypress Sharpridge (CYS) at Outperform; Strong Management Team
Tweet
Share
E-mailGet Alerts CYS Hot Sheet
Price: $7.31 --0%
Rating Summary:
2 Buy, 12 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Rating Summary:
2 Buy, 12 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Join SI Premium – FREE
Wells Fargo initiates coverage on Cypress Sharpridge (NYSE: CYS) with an Outperform. PT range $14-15.
Analyst, Joel Houck, said, "Our Outperform rating is based on (1) CYS’s strong and seasoned management team; (2) internally managed entity in which company management and investor interests are aligned; and (3) strong risk management. We believe CYS is strong in the agency space and provides investors with a balanced approach in an environment where both prepayment and extension risk exist. We are establishing 2012 and 2013 EPS estimates of $2.23 and $2.21, respectively."
For an analyst ratings summary and ratings history on Cypress Sharpridge click here. For more ratings news on Cypress Sharpridge click here.
Shares of Cypress Sharpridge closed at $13.65 yesterday.
Analyst, Joel Houck, said, "Our Outperform rating is based on (1) CYS’s strong and seasoned management team; (2) internally managed entity in which company management and investor interests are aligned; and (3) strong risk management. We believe CYS is strong in the agency space and provides investors with a balanced approach in an environment where both prepayment and extension risk exist. We are establishing 2012 and 2013 EPS estimates of $2.23 and $2.21, respectively."
For an analyst ratings summary and ratings history on Cypress Sharpridge click here. For more ratings news on Cypress Sharpridge click here.
Shares of Cypress Sharpridge closed at $13.65 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo Starts Huntington Bancshares (HBAN) at Overweight
- Craig-Hallum Starts Horizon Quantum (HQ) at Buy
- Wedbush Starts Immunic Inc. (IMUX) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Wells FargoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
